CURRICULUM VITAE - University of Michigan College … · Web viewCURRICULUM VITAE Varsha Mehta, MS (Medicinal Chemistry), MS (Clinical Research Design and Statistical Analysis), Pharm.D

Varsha Mehta (Bhatt-Mehta)

Curriculum Vitae June 2013

CURRICULUM VITAE

Varsha Mehta, MS (Medicinal Chemistry), MS (Clinical Research Design and Statistical Analysis), Pharm.D FCCP

(Publications under –Varsha Bhatt-Mehta)ADDRESS

Residence 468 Pine Brae StreetAnn Arbor, MI 48105

Office Department of Clinical, Social and Administrative SciencesCollege of PharmacyUniversity of Michigan428 Church Street

Telephone: 734-936-8985 (office) 734-763-6629 (Admin)Fax: 734-936-6964 734-763-4480

Place of Birth Kampala, Uganda

UM Tax ID Number 38-6006309-W

Licensure State of Michigan #5302028098 May, 1990

State of Ohio # 03-2-16706, September, 1987

EMPLOYMENT

ACADEMIC APPOINTMENTS2012-present Clinical Professor

College of PharmacyUniversity of Michigan

2012-present Clinical Professor Pediatrics and Communicable Diseases University of Michigan Medical School

1997-2012 Clinical Associate ProfessorCollege of PharmacyUniversity of Michigan

2001-2012 Clinical Associate Professor Pediatrics and Communicable Diseases University of Michigan Medical School

1



1989-1997 Clinical Assistant ProfessorCollege of PharmacyUniversity of Michigan

1987-1989 InstructorCollege of PharmacyOhio State University

CLINICAL/HOSPITAL APPOINTMENTS

1989-present Clinical Pharmacist, University of Michigan Hospitals:

Neonatal Intensive Care Unit (1989-1996)Pediatric Intensive Care Unit (1996-2003)Neonatal Intensive Care Unit (2003-present)

1982-1985 Staff Pharmacist Charring Cross Hospital London, UK

CONSULTING POSITIONS

Expert case review- Legal cases of drug therapy issues in pediatric patients

EDUCATION

2005-2007 Master of Science in Clinical Research Design and Statistical Analysis School of Public HealthUniversity of MichiganMichigan, USA(Supported by the K30 Program)

1985-1987 Doctor of Pharmacy College of PharmacyUniversity of CincinnatiOhio, USA

1981 Special one-year full time prerequisite course for overseas pharmacistsSunderland PolytechnicEngland, UK

1977-1979 Master of Science in Medicinal Chemistry LM College of Pharmacy, Gujerat UniversityAhmedabad, India

1974-1977 Bachelor of Science in PharmacyLM College of Pharmacy, Gujerat University

2


Curriculum Vitae June 2013Ahmedabad, India

POSTDOCTORAL TRAINING

9/ 2005 K12 RR017607-01 (Schteingart) NIH/NCRR -8/ 2008 “Michigan Mentored Clinical Scholars Program" This is a specialized

program providing salary support to train physicians and other healthcareprofessionals in clinical research which augments the K30 TrainingProgram in Clinical Research. The program involves courses in biostatistics, specialized clinical research seminars, a mentored clinicalresearch project and monthly discussions of research work by the scholarsin a tailored curriculum dependent upon scholars' experience and clinicalresearch exposure. Scholars are also instructed on federal regulation ofclinical research and IRB requirements.

Role: Scholar

1987-1989 Fellowship - Pediatric PharmacotherapyOhio State University and Children's HospitalColumbus, Ohio, USAMentor: Milap C. Nahata

ADVANCED WORKSHOPS /COURSES

April 2011 Sheiner/Rowland Workshop on Advanced Pharmacokinetics/Pharmacodynamics, Philadelphia, PA

April 2008 Workshop on Modeling Paediatric Medicines, EMEA, London, UK

April 2007 InVitro-InVivo Extrapolation in the prediction of drug absorption, distribution, clearance and drug-drug interactions (Simcyp®), Baltimore, MD

February 2007 Introductory NONMEM® and PDx-POP™ WorkshopGloboMax, Baltimore, MD

February 2006 Introductory NONMEM® and PDx-POP™ WorkshopGloboMax, Baltimore, MD

April 2005 Dale Carnegie Training on Human Relations

September 2004 Institutional Review Board workshop-reporting adverse events for clinical research, University of Michigan IRB

March 2004 Randomized Controlled Trials: Scientific and Ethical PrinciplesCenter for Statistical Consultation and Research, University of Michigan

3



November 2000 Writing winning grants. American College of Clinical Pharmacy And American association of Colleges of Pharmacy, Los Angeles, CA

February, 2000 Current concepts in Pediatric Critical Care, Society of Critical Care Medicine, Orlando, FL

September 1997 Basic SAS, Center for Statistical Consultation and Research,

University of Michigan

June 1997 Applied survival Analysis, Event History analysis, and ReliabilityAnalysis, Center for Statistical Consultation and Research, University of Michigan

May 1997 Sample size determination, Center for Statistical Consultation and Research, University of Michigan

CERTIFICATES, HONORS AND AWARDS

2011 Teaching Excellence Award Finalist, University of Michigan, College of Pharmacy

1999 Fellow -American College of Clinical Pharmacy1995 Full member. Sigma-Xi Honor Society, Michigan Chapter1990 "You are super" certificate of appreciation, Holden Neonatal Intensive

Care Unit, Mott Hospital1987 Rho-Chi Honors Society, University of Cincinnati.1985-87 University of Cincinnati Graduate School Scholarship1977-79 Gujerat University Graduate Scholarship, India.

SCIENTIFIC ACTIVITIES AND ADMINISTRATIVE SERVICE

National

American College of Clinical Pharmacy (ACCP)

2006 Fellowship Program Review Committee-2009

2010 Invited Judge -Resident, Student, Fellow Poster Awards Judging Committee



4



2005 Annual Program Planning Committee

2004 Invited Judge - Resident, Student, Fellow Poster Awards Judging Committee

2003 Chair, Program Planning Committee of Pediatrics Practice and Research Network International Congress on Clinical PharmacyConference of the American College of Clinical Pharmacyand European Society of Clinical Pharmacy

2002 Program Planning Committee Spring Practice and Research Forum

2000 Fellowship Subcommittee of Credentials Committee-2001

1999 Program Planning Committee Spring Practice and Research Forum-2000

1999 Chair, Program Planning Committee of Pediatrics PRNSpring Practice Research Forum

1991 Public and Professional Relations Committee -1993

Offices held:

2011 Chair Elect Pharmacodynamics/Pharmacokinetics/Pharmacogenomics Practice and Research Network

1996 Chair, Pediatric Practice and Research Network

Pediatric Pharmacy Advocacy Group (PPAG)

1995-2002 Annual Conference Organization Committee

1995-2003 Research and Education Committee

2002-2004 Chair, Abstract Review Committee

Office held:

2002-2004 Chair, Research Committee

Society of Critical Care Medicine (SCCM)

5



2002-2005 Education Sub CommitteeClinical Pharmacy and Pharmacology Section (CPP)

2003-2005 CPP Task force On Pediatric Drug Safety

Editorial Board Membership

2003-present Annals of Pharmacotherapy

Peer Reviewer for Scientific Journals and Meetings

2009-present Clinical Pharmacology and Therapeutics2003-present Journal of Perinatology2003-present Journal of Pediatric Pharmacology and Therapeutics2003-2005 Scientific Abstract Reviewer, Clinical Pharmacy and

Pharmacology Section, SCCM2001-present Pediatric Critical Care Medicine journal 2000-present Critical Care Medicine journal1995-2004 Scientific Abstract Reviewer, PPAG1997-present Clinical Pharmacokinetics 1996-present Annals of Pharmacotherapy1992-present Pharmacotherapy1992-present American Journal of Health-System Pharmacy1992-present Scientific Abstract Reviewer for Annual Meeting abstracts and

Spring Practice and Research forums1992-1993 Clinical Pharmacy

MEMBERSHIPS IN PROFESSIONAL SOCIETIES1987-present American College of Clinical Pharmacy

(including Practice and Research Networks)PediatricsPharmacokinetics/ Pharmacodynamics/Pharmacogenomics

2006-2008 American Association of Pharmaceutical Sciences1998-2005 Society of Critical Care Medicine1992-2005 Pediatric Pharmacy Advocacy Group1986-1999 American Society of Hospital Pharmacists1983-1987 Pharmaceutical Society of Great Britain

Local

University of Michigan

Membership in University Senate Assembly Committees

2000-2001 Chair, Committee on Economic Status of Faculty (CESF) 2002-2004 Committee on Economic Status of Faculty (CESF) 1998 –2000 Committee on Economic Status of Faculty (CESF)

6



2007-2010 Senate Advisory Committee on University Affairs-Member, Rules Committee (SACUA)

Department of Pediatrics

2000-2009 Core Faculty Child Health Research and Evaluation Unit (CHEAR)2005-2008 Neonatal-Perinatal Medicine Fellowship Program Scholarly Oversight

Committee

College of Pharmacy

College of Pharmacy Committees

2012-present Chair, Faculty Development Committee2012-present Member, International Committee2011-2012 Member, Faculty Development Committee2009-present International Faculty Host2009-2011 Member, Practitioner Relations Committee2009-2011 Member, Admissions Committee2004-2009 Member, Pharm. D. Investigations committee 2004-2005 Member Pharm. D. investigations curriculum committee 2003-2004 Member, Promotions Committee, Clinical Faculty 2003-2004 Member, Practitioner Relations Committee2003-2004 Member, Clinical Research Resource Committee 2002-2004 Member, Curriculum Committee on therapeutics Review 1999-2003 Member, Executive Committee, College of Pharmacy 1999-2000 Chair, Promotions Committee, Clinical faculty 1997-1999 Member, By-laws committee of the College of Pharmacy

College of Pharmacy Committees, Ad Hoc

2009-2012 Curriculum subcommittee on Evidence Based Medicine course development

Department of Pharmacy1998-2000 Residency Advisory Committees (1998-2000)2000-2002 Clinical Documentation Committees (2000-2002)1992-present Ad Hoc Committees (various)

University Health Systems

1990-present Neonatal Intensive Care Joint Practice Committee 2001-2007 Mott CPR Committee 1997-2005 Pediatric Medical and Surgical Joint Practice Committees 1997-2003 Pediatric Intensive Care Quality Assurance Committees 1996-2003 Pediatric Intensive Care Joint Practice Committee 1995-1997 Pediatric Cardiothoracic Unit Joint Practice Committee1994-1997 Nurse Practice Committee

7



Community service

1986-1987 American Red Cross Cincinnati Area Chapter1985-1986 Volunteer international student speakers 1985-1987 The Holiday Project, Columbus and Cincinnati1993-1996 Board Member, University of Michigan Child Care Center 1992-present Volunteer, Interpreter Services, University of Michigan 2000-present Volunteer, the Jain temple, Farmington Hills, MI2007-present Volunteer, Healthy Asian American Project

GRANT AND CONTRACTS PENDINGSource and DURATA TherapeuticsValue of support ~$50,000 (in negotiations)Project Title Phase I study of dalbavancin in pediatric patientsPrincipal Investigator Bhatt-Mehta, V (Site PI)

Source and National Institute of Drug Abuse R21Value of support ~$225,000.00Project Title Pharmacokinetics/Pharmacodynamics of methadone in

newborn infants.Principal Investigator Bhatt-Mehta, V

GRANT AND CONTRACTS RECEIVEDSource and Clinical and Translational Science Award,

University of MichiganValue of support $5,000.00Project Title Pharmacodynamics of hydrocortisone in newborn infants.Principal Investigator Bhatt-Mehta, V

Awarded May 2008

Source and Clinical and Translational Science Award, University of Michigan

Value of support $35,000.00Project Title Validation of the m NPASS scalePrincipal Investigator Bhatt-Mehta, V

Awarded April 2008

Source and NICHD/FDA (via Duke Clinical Research Institute-PI: Danny Benjamin, MD Duke University)

Value of support $200,000.00Project Title Meropenem Pediatric Labeling StudyPrincipal Investigator Site PI: Bhatt-Mehta, V

8



Awarded February 2008

Source and Training Programs in Clinical Research/NIHValue of support $274,193.00Project Title K12 RR017607-01 NIH/NCRR

"Michigan Mentored Clinical Scholars Program"Principal Investigator Bhatt-Mehta, V

Awarded September 2005 (9/2005-8/2008)

Source and General Clinical Research Center -$8000.00Value of support Boehringer Ingleheim - $6000.00Project Title Salivary and plasma caffeine concentrations in neonatesPrincipal Investigator Bhatt-Mehta V, Lamar K, Streetman DD, Schumacher RE

Awarded August 2001

Source and Clinical Research Resource Center, College of Pharmacy

Value of support $19,000.00Project Title Drug Clearance during ECMOPrincipal Investigator Bhatt-Mehta, V, Annich G, Custer JR

Awarded April 2001

Source and Organon, Inc.Value of support $34,000.00Project Title A multi-center study of Rocuronium Continuous

infusion in the Pediatric Intensive Care UnitPrincipal Investigator Bhatt-Mehta, V, Moler FW, Custer JR, Annich G

Awarded September 2000

Source and Glaxo-Wellcome, IncValue of support $43,000.00Project Title Evaluation Cisatracurium in infants: A dose finding

study.Principal Investigator Bhatt-Mehta, V; Zahrra; J, Molar; F; Custer, J; Maxvold,N

Awarded July 1997

Source and Clinical Research Resource Center, College of PharmacyValue of support $17,000.00Project Title Evaluation of inhalational dexamethsone in infants at

risk for bronchopulmonary dysplasia: A dose finding study.

Principal Investigator Bhatt-Mehta, V

Awarded July 1996

Source and approximate Clinical Research Resource Center, College of Pharmacy

9



Value of support $4350Project Title Stability and compatibility of Midazolam and

atracurium injection during co-infusionPrincipal Investigator Bhatt-Mehta, V

Awarded April, 1996

Source and approximate O.P.R. DevelopmentValue of support $15,000Project Title Clinical Evaluation of sterile Caffeine Citrate in the

Treatment of Apnea of PrematurityPrincipal Investigator Donn SM, Bhatt-Mehta V, Schumacher RE.

Awarded February, 1995

Source and Burroughs Wellcome Co.Value of support $30,000Project Title Proximal vs Distal Administration of Exosurf: Effect on

incidence of untoward side effects seen during dosing.Principal Investigator Bhatt-Mehta V, Schumacher RE

Awarded April, 1994

Source and Pfizer Inc. Value of support $ 59,409Project Title An open, comparative multicenter study of Fluconazole

vs Amphotericin B in the treatment of life-threatening systemic Candida infection in pediatric patients

Principal Investigator Bhatt-Mehta, V.

Awarded April, 1992

Source and Astra PharmaceuticalsValue of support $ 1000Project Title Caudal epidural morphine for control of postoperative

pain in children undergoing cardiac surgeryPrincipal Investigator Rosen DA, Bhatt-Mehta, V.

Awarded January 1992

Source and Abbott Laboratories Value of support $ 1200Project Title Pharmacokinetics of gentamicin in neonates on ECMO:

controlled, prospective study.Principal Investigator Bhatt-Mehta, V.

Awarded December 1991

Source and Roche Laboratories Value of support $ 1500Project Title Pharmacokinetics of oral Midazolam in infants and

children

10



Principal Investigator Bhatt-Mehta, V.

Awarded June 1991

Source and Stuart PharmaceuticalsValue of support $ 1500Project Title Chronic renal failure in a neonate due to Lisinopril

(Travel support for presentation)Principal Investigator Bhatt-Mehta, V.

Awarded June 1991

Sources and Children's Hospital Research Value of support Foundation, Columbus, Ohio - $ 3200

The Upjohn Company - $ 500Project Title Clinical pharmacokinetics of dopamine in newborn

infantsPrincipal Investigator Bhatt-Mehta, V.

Awarded 1988-89

OTHER SUPPORT:1. Sponsor: State of MI, Community Health Agencies

Medicaid-Pharmacy, Project/Grant # F010395, 2002-2006

INVITED PRESENTATIONS

INVITED LOCAL, NATIONAL AND INTERNATIONAL PRESENTATIONS

Local

1. Neonatal Respiratory Distress Syndrome- Fall Seminar Series, College of Pharmacy, University of Michigan. (September 1992)

2. Perils of theophylline - Continuing medical education lecture for the fall 1995 Section of Neonatology Continuing Medical Education Conference, University of Michigan, (October 1995).

3. Complications of Prematurity - Continuing pharmacy education lecture. St Joseph’s Hospital, Department of Pharmacy, Ann Arbor, MI, August 1995

4. Sedation and Analgesia in The Pediatric Patient: Monthly lecture series for Physicians –in –training, Pediatric intensive Care Unit, University of Michigan (1999-2003)

11



5. Pediatric Pharmacology: An invited lecture for Physicians in Training-Pediatric Intensive Care Unit and Pediatric Cardiothoracic Unit, University of Michigan (November 2002)

6. Neonatal Pharmacokinetics. An invited lecture for Physicians in Training-Neonatal Intensive Care Unit, University of Michigan (January 2004)

7. Neonatal Parenteral Nutrition. An invited lecture for Physicians in Training-

Neonatal Intensive Care Unit, University of Michigan (August 2004)

8. Advocating Clinical Research: My experience with pediatrics. An invited lecture for Department of Clinical, Social and Administrative Sciences, College of Pharmacy, University of Michigan (October 2008)

9. Prophylactic treatment of Patent Ductus Arteriosus. An invited research seminar for Department of Clinical, Social and Administrative Sciences, College of Pharmacy, University of Michigan (May 2011)

10. Pharmacokinetics/Clinical Pearls in Infectious diseases in the NICU. An invited presentation for Physicians in the Neonatal Intensive Care Unit, University of Michigan (October 2012)

11. OJOC and Beyond! An invited presentation for the School of Public health On-Job-On-Campus program. November 2012.

National

1. Practical approaches to sedation: Strategies for Pediatric Patient (Workshop). Third Annual Pediatric Technology Conference, Napa, California, 1994

2. Chair, Round Table discussion – Pediatric and Neonatal HIV infections. Third Annual Pediatric Technology Conference, Napa, California, September, 1994.

3. Children in pain: Meeting the challenge. Pharmacokinetics of analgesics. Pediatric Pain Conference. Continuing education lecture - Dearborn, Michigan. April 1997

4. Sedation and paralysis in the ventilated pediatric patient. Lecture at the American College of Clinical Pharmacy annual meeting, Kansas City, KS. November, 1999.

5. Multidisciplinary approach in reviewing complex cases in critically ill pediatric patients: interactive session. Society of Critical Care Medicine, Orlando, FL. February 2000.

12



6. Pediatric Pharmacy Practice and Research - bridging the gap. Wayne State University College of Pharmacy, and Allied Health Sciences. Detroit, MI, November 2008

7. Ethical Dilemmas in the Care of the Newborn Infant and JAINISM. Conference on Bioethics, Claremont-Lincoln University, CA. August 2012

International1. Nine - Lecture series as expert visitor for the Singapore Department of

Health and Human Services Health Manpower Development Program (HMDP). July 2004.

a. Pediatric Pharmaceutical Care.

b. How to Develop Clinical Practice Guidelines.

c. Pharmacokinetic Services Development.

d. Pharmacist education and Continuing Education

e. Pediatric Medication Safety.

f. Pediatric Medication Safety-an institutional experience

g. Pharmacokinetics and Pharmacodynamics in Clinical Practice-Basic principals

h. Neonatal and pediatric Pharmacokinetics and Pharmacodynamics

i. Justifying a Critical Care Pharmacist Position

2. Clinical Pharmacy Practice in the USA. Manipal College of Pharmacy, Manipal, India. January 2013

3. Community Pharmacy Practice in the USA. Manipal College of Pharmacy, Manipal, India. January 2013

OTHER PRESENTATIONS

NATIONAL AND INTERNATIONAL ORAL RESEARCH PRESENTATIONS

1. Bhatt-Mehta V, Johnson CE, Schumacher RE. Pharmacokinetics of gentamicin in neonates on ECMO. Midyear Clinical Meeting of the American Society of hospital Pharmacists, December 1990, Las Vegas, Nevada

2. Bhatt-Mehta V, Rosen D. Pharmacodynamic effects of oral Midazolam in infants and children. Annual meeting of the American College of Clinical Pharmacy, Minneapolis, MN, August 1991.

13



3. Rosen DA, Rosen KR, Bhatt-Mehta V. Alfentanil and propofol for bone marrow procedures: A dose-response study. American Academy of Pediatrics, Spring Session, April 1992

4. Rosen KR, Rosen DA, Callow L, Bove EL, Reynolds PI, Shayevitz JR, Malviya SV, Wilton SVT, Lupinetti FM, Bhatt-Mehta V. Caudal epidural morphine for the control of postoperative pain in children undergoing cardiac surgery. American Academy of Pediatrics, spring Session, April 1992.

5. Klarr JM, Faix RG, Pryce CJ, Bhatt-Mehta V. Randomized blinded trial of dopamine versus dobutamine for hypotension in preterm infants with RDS. 1993 Annual Meeting of the American Academy of Pediatrics, Perinatal Pediatrics Section.

6. Bhatt-Mehta V, Schumacher RE, Faix RG, Stirrup M, Brenner T. Vancomycin Nephrotoxicity in newborn infants: A case-control study. 1997 Annual Meeting of the American College of Clinical Pharmacy. November, 1997.

7. Bhatt-Mehta, V, Sweet G, Gadinzki C. Use of Nicardipine for Hypertensive Urgencies in the Pediatric Intensive Care Unit. American College of Clinical Pharmacy, Annual Meeting, Los Angeles, California. November 2000.

8. Gadzinski C, Sweet B, Bhatt-Mehta, V. Use of intravenous Nicardipine during hypertensive emergencies in critically ill pediatric patients. ASHP Mid-Year Clinical Meeting, Las Vegas, NV. December 2000.

9. Bhatt-Mehta V, Donn SM. Gentamicin pharmacokinetics in full term infants on HFOV. Presented at the 19th Annual Conference on High Frequency Oscillation of infants. Snowbird, UT, April 2002.

10. Subramanian A, Bhatt-Mehta V, Comminsky E, Dawson M, Applebe K. Pediatric Medication Errors. Presented at the Annual Great Lakes Residency Conference, April 2002.

11. Bhatt-Mehta, V, Comminsky E, Dawson M, Applebe K. Pediatric medication safety: an institutional experience. Presented at the second International Conference of the American College of Clinical Pharmacy and European Society of Clinical Pharmacy, Paris, France. April 2004.

12. Bhatt-Mehta, V, Williams P, Vazquez DM, Barks JD.Population Pharmacokinetics of Hydrocortisone in neonates with pressor resistant hypotension. Presented at the Third International Conference of the American College of Clinical Pharmacy and European Society of Clinical Pharmacy, Orlando. FL. April 2009.

13. Bhatt-Mehta V, Barks JD. Reliability and Validity of the sedation subscale of the modified neonatal Pain, Agitation and Sedation Scale (mN-PASS). 52nd Annual Meeting of the European Society for Paediatric Research, New Castle, UK. October, 2011.

14



SESSION MODERATOR1. Neonatal pulmonary complications and treatment strategies: ECMO vs NO

and incorporating steroid therapy for pulmonary insufficiency. Fourth Annual Pediatric Technology Conference, Newport, Rhode Island, September, 1995.

2. Drug use during pregnancy: Pharmaceutical Considerations. Fourth annual Pediatric Technology Conference, Newport, Rhode Island, September, 1995.

3. Pharmacologic Management of Pain in Neonates. Fourth Annual Pediatric Technology Conference, Newport, Rhode Island, September, 1995.

4. Transplantation in Pediatric Patients. American College of Clinical Pharmacy Practice and Research Forum, Palm Springs, California, April 1998.

5. Advances in the treatment of Perinatal HIV infections. American College of Clinical Pharmacy-European Society of Clinical Pharmacy (ACCP-ESCP) International Conference, Orlando, Florida, April 1999.

6. Pediatrics and Patient Safety: Focus on Pediatric Medication Errors. American College of Clinical Pharmacy –European society of Clinical Pharmacy (ACCP-ESCP) International Conference, Paris, France. April 2004

7. Oral Research presentation. Pediatric Pharmacy Advocacy Group. Annual meetings October 2002-October 2004.

8. Novel approaches to adverse drug reactions. American College of Clinical Pharmacy Annual Meeting, San Francisco, CA. October 2005

BIBLIOGRAPHY

Peer Reviewed Journals

1. Bhatt V, Nahata MC. Pharmacotherapy of patent ductus arteriosus. Clin Pharm. 1989; 8:17-33.

2. Bhatt V, Nahata MC. Determination of exogenously administered dopamine in plasma using high performance liquid chromatography with electrochemical detection. J of Liq Chromatogra.1989; 12:1463-71.

3. Bhatt-Mehta V, Nahata, MC. Dopamine and dobutamine in pediatric therapy. Pharmacotherapy. 1989; 9:303-14.

4. Bhatt-Mehta V, Nahata MC. The in-vitro stability of dopamine and theophylline, tolazoline, and dobutamine. J Perinatol. 1990; 10:129-133.

5. Bhatt-Mehta V, Johnson C E, Schumacher R E, Pharmacokinetics of Gentamicin in neonates on extracorporeal membrane oxygenation. Clin Res 1990;38:897A.

15



6. Bhatt-Mehta V, Nahata MC, McClead RE, Menke JA. Clinical pharmacokinetics of dopamine in newborn infants. Eur J Clin Pharmacol 1991:40:593-97.

7. Bhatt-Mehta V, Rosen D. Acute Pain Management in the Pediatric Patient. Clin Pharm 1991; 10:667-85.

8. Bhatt-Mehta V, Johnson C E, Schumacher R E. Pharmacokinetics of gentamicin in neonates on extracorporeal membrane oxygenation. Pharmacotherapy 1992; 12:28-32.

9. Bhatt-Mehta V, Schumacher RE. Criteria for use of synthetic surfactant (Exosurf NeonatalR) in newborn infants. Clin Pharm 1992;11:355-57.

10. Rosen DA, Bhatt-Mehta V, Rosen KR, Lomann A. Oral sedation of infants and children in the ICU: A pharmacokinetic and pharmacodynamic study. Anesth Analg 1992; 74:S256.

11. Bhatt-Mehta V, Rosen DA, King R, Maksym C. Physical compatibility and chemical stability of midazolam hydrochloride in parenteral nutrition solutions. Am J Hosp Pharm 1993;50:285-288.

12. Bhatt-Mehta V, Johnson CJ, Kostoff L, Rosen DA. Stability of Extemporaneously prepared midazolam hydrochloride in flavored gelatin. Am J Hosp Pharm 1993; 50:472-475.

13. Bhatt-Mehta V, Deluga K. Fetal exposure to angiotensin-converting enzyme inhibitor Lisinopril-Neonatal manifestations and management. Pharmacotherapy 1993; 13:515-518.

14. Klarr JM, Faix RG, Pryce CJE, Bhatt-Mehta V. A randomized, blinded, trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome. J Pediatr 1994:124:117-122.

15. Klarr JM, Bhatt-Mehta V, Donn SM. Neonatal adrenergic blockade following single dose maternal labetalol administration. Am J Perinatol. 1994; 11:91-93.

16. Johnson CE, Bhatt-Mehta V, Mancari S, McKown J. Stability and Compatibility of Morphine Sulphate and Midazolam Hydrochloride during intravenous co-administration. Am J Hosp Pharm. 1994;51:2812-15.

17. Bhatt-Mehta V, Paglia R, Rosen DA. Stability of Propofol with parenteral nutrient solutions during simulated y-site injection. Am J Health-Syst Pharm. 1995:52; 192-96.

18. Bhatt-Mehta V, Johnson CE, Donn SM, Thiesen V. Accuracy and reliability of dosing equations to individualize Theophylline treatment in apnea of prematurity. Pharmacotherapy. 1995; 15:246-50.

19. Bhatt -Mehta V, Johnson CE, Leninger N, Agarwal M. Stability and Compatibility of Fentanyl Citrate and Midazolam Hydrochloride During intravenous co-administration. Am J Health-Syst Pharm. 1995; 52:511-13.

16



20. Bhatt-Mehta V, Donn SM, Schork AM, Reed S, Johnson CE. Prospective evaluation of two dosing equations for theophylline in premature infants. Pharmacotherapy. 1996; 16:769-776.

21. Bhatt-Mehta V. Current guidelines for the treatment of acute pain in children. Drugs. 1996;51:760-776.

22. Nelson M, Schumacher RE, Nicks JJ, Becker MA, Vrlenich LA, Bhatt-Mehta V, Schumacher RE . Comparison of two methods of surfactant administration and the effect on dosing associated hypoxemia. J Perinatol. 1997; 17: 450-454

23. Bhatt-Mehta V, Michaels, A, Hirata S. Stability and compatibility of Atracurium besylate and Midazolam Hydrochloride during y-site co-infusion. Intn’l J Pharm Comp 1998; 2:79-82

24. Bhatt-Mehta V, Rosen R. Sedation in Children: Current Concepts. Pharmacotherapy. 1998; 18:790-807.

25. Bhatt-Mehta, V, Schumacher RE, Faix G, Leady M, Brenner T. Vancomycin Nephrotoxicity in Newborn infants. Pediatrics 1999; 103:1-4e.

26. Rorstad A, Bhatt-Mehta, V. Outpatient management of Asthma in children. Pharmacy Times. 2000; May: 55-66.

27. Fiore, T, Chapman R, Bhatt-Mehta V, Pearlman, M, Faix, R. Maternal and Transplacental Pharmacokinetics of Cefazolin for Intrapartum Prophylaxis of Group B Streptococcal In fection in Penicillin-allergic women. Obstetrics and Gynecology 2001; 98:1075-1079

28. Odetola F, Bhatt-Mehta V, Moler F, Zahrra J, Custer J. Pharmacokinetics of Cisatracurium in infants 0-2 years in a pediatric intensive care unit: An open label study. Pediatr Critic Care .2002; 3:250-54.

29. Streetman DA, Bhatt-Mehta, V, Johnson CJ. Treatment of acute asthma in children. Ann Pharmacotherapy 2002; 36:1249-1260

30. Bhatt-Mehta V, Schumacher RE. Treatment of Apnea of Prematurity (Invited review). Paediatr Drug 2003; 5:195-210.

31. Bhatt-Mehta V, Donn SM. Gentamicin pharmacokinetics in neonates receiving high frequency oscillatory ventilation and conventional mechanical ventilation. J Perinatol 2003; 23:559-62.

32. Sadowski R, Dechert RE, Bandy KP, Juno J, Bhatt-Mehta V, Custer JR, Moler FW, Bratton SL. Continuous Quality Improvement: Reducing Unplanned Extubations in a Pediatric Intensive Care Unit. Pediatrics 2004; 114:628-632.

33. Bhatt-Mehta, V, Donn SM. Letter to editor. Gentamicin pharmacokinetics in neonates receiving high frequency oscillatory ventilation and conventional mechanical ventilation. J Perinatol. 2004: 24, 266 - 267

17



34. Bhatt-Mehta V, Annich G. Drug clearance during ECMO- Morphine and Lorazepam. Perfusion. 2005; 20:309-15.

35. Calhoun D, Ludtke S, Murthy NS, Bryant BG, Bhatt-Mehta, V. Recent advances in neonatology. Ann Pharmacotherapy. 2006;40:710-19.

36. Baker C, Schumacher RE, Barks J, Vazquez D, Bhatt-Mehta, V. Evaluation of Hydrocortisone in neonates with pressor resistant hypotension.J Perinatol 2008; 28, 412-419.

37. VanLooy JW, Schumacher RE, Bhatt-Mehta, V. Efficacy of a Premedication Algorithm for Nonemergent intubation in a neonatal Intensive Care Unit. Ann Pharmacother 2008, 42:947-55.

38. Lattimore KA, Vazquez DM, Barks JD, Bhatt-Mehta, V. Developmental outcomes of very low birth weight infants treated with hydrocortisone for refractory hypotension. J Neonatal-Perinatal Medicine 2008; 1:225-232.

39. Attar, Mohammad A, Bhatt-Mehta, V, Hieber S, Schumacher R E.Can Prophylactic PDA Treatment Decrease Utilization of Hospital Resources?

J of Neonatal-Perinatal Medicine 2009; 2:175-179

40. Bhatt-Mehta, V, Barks JD. Free vs total cortisol in the treatment of relative adrenal insufficiency of the newborn. Journal of Neonatal-Perinatal Medicine 2011;4:247-252.

41. Smith PB, Cohen-Wolkowiez, M, Castro, L, Poindexter, B, Bidegain M, Weitkamp JH, Schelonka, LR, Ward, RM, Wade, K, Valencia, G, Burchfield, D, Arrieta, A, Bhatt-Mehta, V, Walsh, M, Kantak, A, Rasmussen, M, Sullivan, JE, Finer, N, Brozanski, BS, Sanchez, P, van den Anker, J, Blumer, J, Kearns, G, Capparelli, EV, Anand, R, Benjamin Jr. DK on behalf of the Meropenem Study Team.Population Pharmacokinetics of Meropenem in Plasma and Cerebrospinal Fluid in Infants with Suspected or Complicated Intra-abdominal Infections. Pediatr Infect Dis J 2011;30:844-849.

42. Shellhas R, Ng, C, Dillon C, Barks J, Ng, C, Bhatt-Mehta, V. Population Pharmacokinetics of Phenobarbital in Infants with Neonatal Encephalopathy treated with Therapeutic Hypothermia. Pediatr Crit Care Med 2013;14:???

43. Cohen-Wolkowiez M, Poindexter B, Bidegain M, Weitkamp JH, Schelonka RL, Randolph DA, Ward RM, Wade K, Valencia G, Burchfield D, Arrieta A, Bhatt-Mehta V, Walsh M, Kantak A, Rasmussen M, Sullivan JE, Finer N, Rich W, Brozanski BS, van den Anker J, Blumer J, Laughon M, Watt KM, Kearns GL, Capparelli EV, Martz K, Berezny K, Benjamin DK Jr, Smith PB; for the Meropenem Study Team.

18



Safety and Effectiveness of Meropenem in Infants With Suspected or Complicated Intra-abdominal Infections. Clin Infect Dis. 2012 Dec; 55(11):1495-1502.

44. Bhatt-Mehta V, Ng CM, Schumacher RE. Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in-utero drug exposure to substances of abuse. Pediatr Crit Care Med (In press- PCCM-D-13-00048R2)

Submitted

45. Attar MA, Vasileff AS, Schumacher RE, Wojtecki JA, Bhatt-Mehta, V. Prophylactic treatment of patent ductus arteriosus in premature neonates –is it worth it? (Under review –Journal of Asian Pediatrics)

In preparation:46. Venzia H, Ng CM, Vazquez, D, Schumacher RE, Bhatt-Mehta, V. Population

Pharmacokinetics of unbound cortisol in neonates with pressor resistant hypotension.

Non-peer reviewed journals/manuals/Books.

1. Rosen DA, Rosen KR, Bhatt-Mehta V. Options for continuous sedation in the pediatric intensive care unit. Excerpta Medica. June, 1991.

2. Bhatt-Mehta, V, Donn SM.Neonatal Pharmacokinetics. In: Donn SM(ed): The Michigan Manual of Guide to Neonatal Intensive Care. Futura Publishing Co.,Mt Kisco, NY, 1996, 2003.

3. Bhatt-Mehta, VDrugs in Breastfeeding. In: Donn SM (ed). The Michigan Manual of Guide to Neonatal Intensive Care. Futura Publishing Co., Mt. Kisco, NY, 1996, 2003.

4. Bhatt-Mehta, V, Donn SM.Neonatal Drug Formulary. In: Donn SM (ed). The Michigan Manual of Guide to Neonatal Intensive Care. Futura Publishing Co., Mt. Kisco, NY, 1996, 2003.

5. Bhatt-Mehta, V, Donn SM.Effects of maternal drug administration on the Fetus and the Newborn. In: Donn SM (ed). The Michigan Manual of Guide to Neonatal Intensive Care. Futura Publishing Co., Mt. Kisco, NY, 1996, 2003.

19



6. Bhatt-Mehta, V, Schumcaher RE.Criteria for Drug Use Evaluation, Surfactants. Volume 4, 1994. Publication of the American Society of Hospital Pharmacists.

7. Bhatt-Mehta, VPrescription Drugs for Children. A Consumer Guide. International Publications, Lincolnwood, Chicago, IL. 1997.

8. Bhatt-Mehta, VPediatric Critical Care In: Lake K et al. (eds) Pharmacotherapy Self-Assessment Program –Pediatrics Module. American College of Clinical Pharmacy, Kansas City, MO January, 2000.

9. Bhatt-Mehta, VIntroduction to Neonatology In: Nahata MC, Caballero, S (eds) Pediatric Pharmacotherapy, American College of Clinical Pharmacy, Lenexa, KS (under review) June 2011

10. Bhatt-Mehta V, Donn SM. Pharmacologic agents. In Donn SM, Sinha SK (Eds.). Manual of Neonatal RespiratoryCare, 3rd edition. New York, Springer Science+ Business Media, LLC 2012

11. Bhatt-Mehta V. Introduction to neonatology. In: Benavides S, Nahata MC, eds. Pediatric Pharmacotherapy. Lenexa, KS: American College of Clinical Pharmacy, ISBN: 978-1-932658-89-7; 2012; 850 pages; paperback

12. Bhatt-Mehta V, Donn SM. Pharmacologic agents. In Donn SM, Sinha SK (Eds.). Manual of Neonatal Respiratory Care, 3rd edition. New York, Springer Science 2012.

Invited Editorial

Bhatt-Mehta V. . Should parents use cough and cold preparations for their children? Ann Pharmacother 2004; 38:1964-66.

Letters to EditorBhatt-Mehta V, Barks J, Schumacher RE. Letter to the editor (P3). Pediatrics December 2006. (Ref article: Early prophylaxis of adrenal insufficiency to prevent Bronchopulmonary dysplasia; a multicenter trial. (Watterberg K et al. Pediatrics 2004; 114: 1649-1657)

Book Reviews1. Bhatt-Mehta, V.

Ed: Gerald G Briggs BPharm FCCP, Roger K Freeman MD, and SumnerJ Yaffe MD. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 8th Edition Ann Pharmacother 2009; 43:154-155.

2. Bhatt-Mehta, V.

20



Eds: Richardson, M, Chant, C, Cheeseman KH, Finks SW, Hemstreet BA, Hume AL, et al. Pharmacotherapy Self-Assessment Program, 7th ed. Book 4. Pediatrics. Ann Pharmacother Published Online, 8 Mar 2011, theannals.com DOI 10.1345/aph.1P694

3. Bhatt-Mehta, V. Ed: Gerald G Briggs B.Pharm FCCP, Roger K Freeman MD, and Sumner J Yaffe MD. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 9th Edition Ann Pharmacother 2011;--:--.(submitted)

Opinion/White Papers 1. ACCP PEDIATRICS PRN OPINION PAPER

Recommendations for Meeting the Pediatric Patient's Need for a Clinical Pharmacist: A Joint Opinion of the Pediatrics Practice and Research Network of the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group Bhatt-Mehta, V, Buck ML, Chung, AM, Farrington, EA, Hagmann, TM, Hoff, DS, LaRochelle J M, Pettit, RS, Phan, HP, Potts, AL, Smith, KP, Parrish, RH, II. Pharmacotherapy 2013; 33: 243–251.

2. Recommendations for Meeting the Pediatric Patient's Need for a Clinical Pharmacist: A Joint Opinion of the Pediatrics Practice and Research Network of the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group

Bhatt-Mehta, V, Buck ML, Chung, AM, Farrington, EA, Hagmann, TM, Hoff, DS, LaRochelle J M, Pettit, RS, Phan, HP, Potts, AL, Smith, KP, Parrish, RH, II. Pediatr Pharmacol Ther 2012 Jul-Sep; 17(3): 281–291.

SCIENTIFIC ABSTRACTS ( Presented at National and International Conferences).

1. Bhatt V. In-vitro comparison of three different infusion systems. Thesis presentation. University of Cincinnati College of Pharmacy, July 1987.

2. Bhatt V. Clinical pharmacology of dopamine and dobutamine in newborn infants. Research Conference, Children's Hospital Research Foundation, Columbus, Ohio, September 1987.

21

http://www.ncbi.nlm.nih.gov/pubmed/?term=Parrish%20RH%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Smith%20KP%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Potts%20AL%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Phan%20H%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Pettit%20RS%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=LaRochelle%20JM%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Hoff%20DS%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Hagemann%20TM%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Farrington%20EA%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Chung%20AM%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Buck%20ML%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Bhatt-Mehta%20V%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Parrish%20RH%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Smith%20KP%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Potts%20AL%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Phan%20H%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Pettit%20RS%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=LaRochelle%20JM%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Hoff%20DS%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Hagemann%20TM%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Farrington%20EA%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Chung%20AM%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Buck%20ML%5Bauth%5D

http://www.ncbi.nlm.nih.gov/pubmed/?term=Bhatt-Mehta%20V%5Bauth%5D



3. Bhatt V. Determination of dopamine in plasma using a specific HPLC method. Ninth Annual Children's Hospital and Children's Hospital Research Foundation Research Forum, Columbus, Ohio, June 1988.

4. Bhatt V, Patterson A. In-vitro comparison of three different infusion systems. Mid-year Clinical Meeting of the American Society of Hospital Pharmacists. December 1988, Dallas, Texas.

5. Bhatt V, Nahata MC. In-vitro stability of dopamine and theophylline, tolazoline, and dobutamine. Annual Meeting of the American Society of Hospital Pharmacists,Nashville, TN, June, 1989.

6. Bhatt V, Nahata MC. Pharmacokinetics of Dopamine in critically ill newborn infants. Annual Meeting of the American College of Clinical Pharmacy, Kansas City, Kansas, August, 1989.

7. Bhatt-Mehta V, Johnson CE, Schumacher RE. Pharmacokinetics of gentamicin in neonates on extracorporeal membrane oxygenation. Second International Conference of the Extracorporeal Life Support Organization, Ann Arbor, Michigan, November 1990.

8. Bhatt-Mehta V, Kapai S. Vancomycin serum concentration utilization evaluation in neonates.. Mid-year Clinical Meeting of the American Society of Hospital Pharmacists, December 1990, Las Vegas, Nevada.

9. Jacobson PA, Johnson CJ, Bhatt-Mehta V. Ceftriaxone drug use evaluation in pediatric patients. Mid-year Clinical Meeting of the American Society of hospital Pharmacists, December 1990, Las Vegas, Nevada.

10. Bhatt-Mehta V, Johnson CE, Schumacher RE. Pharmacokinetics of gentamicin in neonates on ECMO. Midyear Clinical Meeting of the American Society of hospital Pharmacists, December 1990, Las Vegas, Nevada.

11. Bhatt-Mehta V, Rosen D. Pharmacodynamic effects of oral Midazolam in infants and children. Annual meeting of the American College of Clinical Pharmacy, Minneapolis, MN, August 1991.

12. Bhatt-Mehta V, Deluga KS. Chronic renal failure in a neonate due to in-utero exposure to Lisinopril. Annual Meeting of the American College of Clinical Pharmacy, Minneapolis, MN, August 1991.

13. Bhatt-Mehta V, King R, Rosen DA, Maksym C, Whitmore R. Physical ompatability and chemical stability of Midazolam with various total parenteral nutrition solutions. Mid-year Clinical Meeting of the American Society of Hospital Pharmcists. December 1991, New Orleans, Louisiana.

14. Rosen DA, Bhatt-Mehta V, Rosen KR. Oral sedation of Infants and children in the Intensive Care Unit: A pharmacokinetic and pharmacodynamic study. International Anaethesia Society Annual Meeting, San Francisco, CA. March 1992.

22



15. Rosen DA, Rosen KR, Bhatt-Mehta V. Alfentanil and propofol for bone marrow procedures: A dose-response study. American Academy of Pediatrics, Spring Session, April 1992.

16. Rosen KR, Rosen DA, Callow L, Bove EL, Reynolds PI, Shayevitz JR, Malviya SV, Wilton SVT, Lupinetti FM, Bhatt-Mehta V. Caudal epidural morphine for the control of postoperative pain in children undergoing cardiac surgery. American Academy of pediatrics, spring Session, April 1992.

17. Bhatt-Mehta V, Paglia R. Physical compatibility and chemical stability of propofol in parenteral nutrition solutions. Mid-year Clinical meeting of the American Society of Hospital Pharmacists, December 1992, Orlando FL.

18. Bhatt-Mehta V, Johnson CJ, Thiesen V, Donn SM. Accuracy and reliability of dosing equations to individualize theophylline treatment in the apnea of prematurity. Annual meeting of the American College of Clinical Pharmacy. August, 1993, Reno Sparks, Nevada.

19. Klarr JM, Faix RG, Pryce CJ, Bhatt-Mehta V. Randomized blinded trial of dopamine versus dobutamine for hypotension in preterm infants with RDS. 1993 Annual Meeting of the American Academy of Pediatrics, Perinatal Pediatrics Section.

20. Agarwal M, Leninger N, Bhatt-Mehta V, Johnson CE. Stability and Compatibility of Fentanyl Citrate and Midazolam Hydrochloride during Intravenous Co-administration. Mid-year Clinical Meeting of the American Society of Hospital Pharmacists. December 1993, Atlanta, Georgia.

21. Mancari SC, McKown J, Johnson CE, Bhatt-Mehta V. Stability and Compatibility of Morphine Sulfate and Midazolam Hydrochloride During Intravenous Co-administration. Mid-year Clinical Meeting of the American Society of Hospital Pharmacists. December, 1993. Atlanta, Georgia.

22. Reed S, Bhatt-Mehta V, Johnson CE, Donn SM. Prospective evaluation of two dosing equations of theophylline in apnea of prematurity. Mid-year clinical meeting of the American Society of Hospital Pharmacists. December 1994. Orlando, Florida.

23. Behm D, Bhatt-Mehta V, Taylor R. Long term use of neuromuscular blockers in a Pediatric intensive care Unit:Observational study. Mid-year Clinical Meeting of the American Society of Hospital Pharmacists. December 1994, Orlando, Florida.

24. Bhatt-Mehta V, Jones C. Pediatric critical care guide for Pediatric Pharmacists. Third Annual pediatric Technology Conference. September 1994, Napa, CA.

25. Bhatt-Mehta V, Donn SM, Schork MA, Reed S, Johnson CE. Prospective evaluation of two dosing equations for dosing theophylline in premature infants. Annual meeting of the American College of Clinical Pharmacy. Washington D.C., August 1995.

23



26. Nelson M, Bhatt-Mehta V, Schumacher RE, Becker M. Comparison of two methods of surfactant administration and the effect on dosing-associated hypoxemia. Annual meeting of the American College of Clinical Pharmacy, Washington D.C., August 1995 AND Society for Pediatric Research regional meeting, September-October 1995.

27. Bhatt-Mehta V, Behm D, Taylor R. Use of non-depolarizing neuromuscular blocking agents in a Pediatric Intensive Care Unit: An observational study. 4 th Annual Pediatric Technology Conference of the Pharmacy Advocacy Group, Newport, RI, October 1995.

28. Bhatt-Mehta V, Wright E, Dwyer S. Implementation of an Intravenous Electrolyte Administration Policy at a Pediatric Teaching Institution. 4 th annual Pediatric Technology Conference of the Pediatric Pharmacy Advocacy Group. Newport, RI. October 1995.

29. Wong G, Brown L, Bhatt-Mehta V. Stability and compatibility of Ketamine HCL and Midazolam HCL during y-site co-infusion. Midyear Clinical meeting of the American Society of Health-System Pharmacists. Las Vegas, NV. December 1995.

30. Michaels A, Hirata S, Bhatt-Mehta V. Stability and compatibility of Atracurium Besylate and Midazolam HCL during y-site co-infusion. Midyear clinical meeting of the American Society of health-System Pharmacists. Las Vegas, NV. December 1995.

31. Bhatt-Mehta V, Jones C. Sedation in the neonatal intensive care unit: Lorazepam or Midazolam? ACCP Winter Forum. Monterey, CA. February 1996

32. Bhatt-Mehta V, Schumacher RE, Faix RG. Gentamicin Pharmacokinetics in neonates on ECMO: A prospective controlled study. ACCP Winter Forum. Monterey CA. February 1996.

33. Bhatt-Mehta V, Hamby C, Donn SM. Gentamicin Pharmacokinetics in neonates receiving high frequency oscillatory ventilation. A Case-matched study. 5th Annual Pediatric Technology Conference of the Pediatric Pharmacy Advocacy group. Scottsdale, AZ. September, 1996.

34. Bhatt-Mehta V, Hamby C, Donn SM. Gentamicin Pharmacokinetics in neonates receiving high frequency oscillatory ventilation. A Case-matched study. American College of Clinical Pharmacy Spring Practice and Research Forum. Panama City, FL. April 1997.

35. Bhatt-Mehta V, Schumacher RE, Faix RG, Stirrup M, Brenner T. Vancomycin Nephrotoxicity in newborn infants: A case-control retrospective study. Annual Meeting of the American College of Clinical Pharmacy. November, 1997.

36. Bhatt-Mehta V, Kapila S. An observational study evaluating the use of milrinone lactate in pediatric cardiothoracic postoperative patients. American

24



College of Clinical Pharmacy Spring Practice and Research Forum. Palm Springs, CA. April, 1998.

37. Bhatt-Mehta V, Schumacher RE, Faix RG, Stirrup M, Brenner T. Vancomycin Nephrotoxicity in newborn infants: A case-control retrospective study. Midwestern Society for Pediatric Research, Chicago, IL September 1998.

38. Bhatt-Mehta V, Kapila S. An observational study evaluating the use of milrinone lactate in pediatric cardiothoracic postoperative patients. 7th Annual Pediatric Pharmacy Advocacy Group Conference, Kiawah Islands, SC. October, 1998.

39. Bhatt-Mehta V, Moler F, Zahrra J, Custer J. Cisatracurium infusion in infants 0-2 years in a pediatric intensive care unit: An open label study. Society of Critical Care Medicine 28th educational and scientific symposium. San Francisco, CA. January 1999.

40. Bhatt-Mehta V, Moler F, Zahrra J, Custer J. Cis-atracurium infusion in infants 0-2 years in a pediatric intensive care unit: An open label study. International Congress on Clinical Pharmacy. American College of Clinical Pharmacy, Orlando, FL. April 1999.

41. Juzysta N, Bhatt-Mehta V. An observational study evaluating thrombocytopenia due to amrinone lactate in pediatric cardiothoracic postoperative patients. Midyear clinical meeting of the American Society of Health-System Pharmacists. Orlando, FL. December 1999.

42. . Odetola F, Bhatt-Mehta V, Moler F, Zahrra J, Custer J. Pharmacokinetics of Cisatracurium in infants 0-2 years in a pediatric intensive care unit: An open label study. Society of Critical Care Medicine 29th educational and scientific symposium. Orlando, Florida, February 2000.

43. Bhatt-Mehta V, Jujzsta N. Comparison of thrombocytopenia due to amrinone and milrinone on pediatric postoperative cardiac surgery patients. Third World Congress on Pediatric Intensive Care. Montreal, Canada. June 2000

44. Chapman R, Fiore, T, Bhatt-Mehta, V, Pearlman, M, Faix, R. Maternal and Transplacental Pharmacokinetics of Cefazolin for Intrapartum Prophylaxis of Group B Streptococcal In fection in Penicillin-allergic women. 2001 Pediatric Academic Societies Meeting, Baltimore, MD. April 2001.

45. Streetman DD, VandenBussche HL, Price J, Bhatt-Mehta, V. Evaluation of amphotericin B deoxycholate and lipid-based amphotericin B in pediatric oncology patients. ASHP Mid-year Clinical Meeting, Las Vegas, NV. December 2000.

46. Bhatt-Mehta V, Hamby C, Donn SM. Gentamicin Pharmacokinetics in neonates receiving high frequency oscillatory ventilation. A Case-matched study. Society of Critical Care Medicine 31st Educational and Scientific Symposium. San Diago, CA. January 2002.

25



47. Phan H, Bhatt-Mehta V, Bratton SL. Compliance with a sedation algorithm accompanied by Physician Standing orders for Ventilated Patients in the Pediatric Intensive Care Unit. ASHP Midyear Clinical Meeting, December 2002, Atlanta, GA

48. Bhatt-Mehta V, Lamar K, Streetman DD, Schumacher RE. Correlation of Serum and Salivary Caffeine Concentrations in premature Infants. 32nd Critical Care Congress, Society of Critical Care Medicine, San Antonio, TX January 2003.

49. Bhatt-Mehta V, Annich G, Custer JR. Effects of extracorporeal membrane oxygenation circuit on Lorazepam. ACCP Spring and Research Forum, Palm Springs CA April 2003.

50. Baker C, Schumacher RE, Barks J, Vazquez D, Bhatt-Mehta, V. Evaluation of Hydrocortisone in neonates with pressor resistant hypotension. Pediatric Academic Societies’ 2005 Annual Meeting. Washington DC. May 2005.

51. Baker C, Schumacher RE, Barks J, Vazquez D, Bhatt-Mehta, V. Evaluation of Hydrocortisone in neonates with pressor resistant hypotension. (Encore) American College of Clinical Pharmacy, San Francisco, CA. October 2005.

52. Bhatt Mehta,V, Williams P, Vazquez D, Barks J. Monte Carlo Simulations for optimized population pharmacokinetic study design of hydrocortisone in neonate. University of Michigan 3M Schools of Pharmacy, Medicine and Public Health collaboration poster dinner. March 2006.

53. Bhatt Mehta,V, Williams P, Vazquez D, Barks J. Monte Carlo Simulations for optimized population pharmacokinetic study design of hydrocortisone in neonate. ACCP Spring and Research Forum, Monterey, CA April 2006.

54. Bhatt-Mehta,V, Neal C Jr, Vazquez D. Effect of early life Glucocorticoid administration on the Limbic-Hypothalamic-Pituitary-adrenal axis stress response. Pediatric Academic Societies’ 2005 Annual Meeting. San Francisco, CA. April-May 2006.

55. VanLooy JW, Tran P, Schumacher RE, Bhatt-Mehta, V. Evaluation of Premedication Algorithm for Non-Emergent Intubation in a Neonatal Intensive Care Unit. Pediatric Academic Societies’ 2007 Annual Meeting. Toronto, Canada. May 2007.

56. Lattimore K, Vazquez D, Barks J, Bhatt-Mehta, V. Developmental Outcome of VLBW infants treated with hydrocortisone for refractory hypotension. Pediatric Academic Societies’ 2005 Annual Meeting. Toronto, Canada. May 2007.

57. Bhatt-Mehta, V, Williams PW, Vazquez D, Neal C, Jr, Barks JDE. Population Pharmacokinetics of Hydrocortisone in neonates with Pressor resistant Hypotension. Annual Clinical and Translational Research Conference. Washington DC. March 2008.

26



58. Bhatt-Mehta, V, Williams PW, Vazquez D, Neal C, Jr, Barks JDE. Population Pharmacokinetics of Hydrocortisone in neonates with Pressor resistant Hypotension. Annual Conference of the Pediatric Academic Societies. Honolulu, HI. May 2008.

59. Mohammad A Attar, Bhatt-Mehta, V, Hieber S, Schumacher, RE.Would Prophylactic PDA Treatment Decrease Hospital Resources Utilization?Midwestern Society for Pediatric Research Annual Meeting, Cleveland OH, October 2008.

60. Smith PB, Capparelli EV, Castro, LM, Valencia G, Bidegain M, Schelonka R, Finer N, van den Anker J, MacKendrick W, Arrieta A, Ward R, Bhatt-Mehta, V, Cohen-Wolkowiez M, Wade KC, Blumer JL, Hope W, Kearns GL, Benjamin DK Jr. on behalf of the Meropenem Study Team. Pediatric Academic Societies Annual Meeting, Baltimore, MD May 2009. Pharmacokinetics and Safety of Meropenem in Young Infants with Intra-Abdominal Infections. A multicenter trial- preliminary results. Pediatric Academic Societies Annual Meeting, Baltimore, MD May 2009.

62. Bhatt-Mehta V, Williams PJ, Vazquez DM, Barks JS. Population Pharmacokinetics of Intravenous Hydrocortisone in Newborn Infants (final results). Pediatric Academic Societies Annual Meeting. Baltimore, MD, May 2009.

63. Bhatt-Mehta V, Barks JD. Free vs Total Cortisol Levels in Treatment of Adrenal Insufficiency in the Newborn. Presented at the third International Conference of the American College of Clinical Pharmacy and European Society of Clinical Pharmacy, Orlando, FL. April 2009.

64. Attar MA, Schumacher RE, Wojtecki J, Hieber S, Bhatt-Mehta, V. Improving practice of prophylactic treatment of patent ductus arteriosus in premature neonates.Pediatric Academic Societies Annual Meeting. Vancouver, BC May 2010.

65. Attar MA, Schumacher RE, Wojtecki J, Hieber S, Bhatt-Mehta, V. Improving practice of prophylactic treatment of patent ductus arteriosus in premature neonates.American College of Clinical Pharmacy Spring Research Forum, Charlotte, NC, April 2010.

66. Smith PB, Capparelli EV, Castro, LM, Valencia G, Bidegain M, Schelonka R, Finer N, van den Anker J, MacKendrick W, Arrieta A, Ward R, Bhatt-Mehta, V, Cohen-Wolkowiez M, Wade KC, Blumer JL, Hope W, Kearns GL, Benjamin DK Jr. on behalf of the Meropenem Study Team.Pharmacokinetics and Safety of Meropenem in Young Infants with Intra-Abdominal Infections. Multicenter trial-Final Results. Pediatric Academic Societies Annual Meeting. Vancouver, BC May 2010.

67. Attar MA, Schumacher RE, Wojtecki J, Hieber S, Bhatt-Mehta, V. Improving practice of prophylactic treatment of patent ductus arteriosus in premature neonates.Mid-year Clinical Meeting of the American Society of Hospital Pharmacists. December 2010.

27



68. Edwin, S, Nielson, J, Bhatt-Mehta, V, Dorch, M, Alaniz, C. Therapeutic anticoagulation with enoxaparin in Obese Patients. Society of Critical Care Medicine 40th Educational and Scientific Symposium, San Diego, CA, January 2011.

69. Bhatt-Mehta, V, Wagner, C, Christensen, M, Barks JD. Reliability and Validity of the sedation subscale of the modified Neonatal, Pain, Agitation and Sedation scale. Pediatric Academic Societies Annual Meeting. Denver, CO, May 2011.

70. Bhatt-Mehta, V, Schumacher, RE. Patterns of use of intravenous caffeine in a Neonatal Intensive care Unit. European Society for Pediatric Research Annual meeting, Newcastle, UK. October 2011.

71. Bhatt-Mehta, V, Wagner, C, Christensen, M, Barks JD. Reliability and Validity of the sedation subscale of the modified neonatal, Pain, Agitation and Sedation scale. European Society for Pediatric Research Annual meeting, Newcastle, UK. October 2011.

72. Schumacher RE, Ng CM, Bhatt-Mehta V. Success of a methadone treatment protocol for neonatal drug withdrawal following in-utero drug exposure to substances of abuse. European Society for Pediatric Research Annual Meeting, Istanbul, Turkey. October 2012.

73. Schumacher RE, Ng CM, Bhatt-Mehta V. Success of a methadone treatment protocol for neonatal drug withdrawal following in-utero drug exposure to substances of abuse. American College of Clinical Pharmacy Annual Meeting, Hollywood, FL. October 2012.

74. Sarkar SS, Bhatt-Mehta V, Sarkar S. Does Maternal Intrapartum Antibiotic Treatment Prolong the Incubation Time Required for Blood Cultures to Become Positive for Infants with Early-Onset Sepsis? Pediatric Academic Societies Annual Meeting. Washington DC May 2013.

Graduate Theses:

1. In-vitro comparison of three different infusion systems. Pharm. D. thesis, University of Cincinnati, 1986.

2. Phytochemical investigations of Sapindus trifoliatus Linn. M.S. (Pharmacy) thesis, Gujerat University, India, 1979.

28



TEACHING ACTIVITIES

Lectures and Courses

College of Pharmacy

2011-present Evidence Based Medicine (P 515)

2010-2011 Pharmaceutical Care (P551)

2009-Present IRB and Regulatory Issues in Research- Pharmacy Resident Research Series

2009-2010 Evidence Based Medicine (P330)

1992-present Course-Pediatric pharmacotherapy (P547)Topics-Neonatal Pharmacotherapy

1992-present Course- Pharm.D. Research (P569)Topic- Guiding Research Projects for Pharm.D. Students

1992-present Course- Pharm.D. Seminar series (P680)Topic- guiding students on preparation and presentation of scientific topics

2003-2004 Course-Investigation Course (P476)Topics-How to do Clinical Research in Pediatrics

2003-2004 Course-OTC Medicine (P431)Topics-OTC Management of Ear, Nose, and Mouth disorders

1992-1999 Course-Applied pharmacokinetics (P562)Topics-Pediatric Pharmacokinetics

University Hospitals

1994-2004 Neonatal Parenteral Nutrition - Lecture for Physicians, Divisions of Neonatology and Pediatric Critical Care, University of Michigan, Ann Arbor, Michigan December 1994-December 2004.

1994-2003 Neonatal /Pediatric Pharmacokinetics - Lecture for Physicians, Divisions of Neonatology and Pediatric Critical Care, University of Michigan, Ann Arbor, Michigan

29



1996-2003 Sedation and Analgesia in Pediatric Critical Care - Lecture for Physicians, Division of Pediatric Critical Care, University of Michigan, Ann Arbor, Michigan

Mentorship

A. Research

a. Postgraduate trainees mentored

I. Department of Pharmacy, University of Michigan Health Systems

Pharmacy Practice Residents or Pediatric Pharmacy Specialty Residents primary research mentor

1. Lori Kostoff 19932. Margaret Tonda 19943. Doug Wong 1996 4. Darcie Streetman 20015. Akila Subramanian 20026. Stephanie Edwin 2010

II Departments of Neonatal-Perinatal Medicine, Division of General Pediatrics and Pediatric Critical Care

University of Michigan Medical School (mentored or co-mentored)

Neonatal-Perinatal Medicine Fellows mentored as primary mentor or co-mentor (1992-present)

Cynthia Pryce, MDJudith Klarr, MDB J Wilson, MDMartha Nelson, MDTina Fiore, MD (Obstetrics)Lisa Oca, MDRachel Chapman, MDCharles Fredrick Baker MDJames Vanlooy MDKerri Lattimore MD

Pediatric Intensive Care Fellows mentored as primary mentor (1996-2003)

Folafoluwa Odetola, MDJihad Zahrra, MD

Pediatric Neurology Junior Faculty co-mentor (2008-2009)Renee Shelhass, MD (K30 trainee)

30



Division of General PediatricsCore facultyNational Institute of Child Health Development (NICHD)T-32 NRSA Training Grant for Pediatric Health Services Research

Division of Neonatal-Perinatal Medicine:Neonatal-Perinatal Medicine Fellowship Program Scholarly Oversight Committee (2005-2010)

b. Doctor of Pharmacy Students Research Projects mentored as primary advisor

Name Acadamic Year1. Sujata B. Kapai 1991-922. Reginald S. King 1991-923. Roseanne Paglia 1992-934. Nina Lininger 1993-945. Mona Agarwal 1993-946. Joe McKown 1993-947. Susan Mancari 1993-948. Virginia Thieson 1993-949. Dena Behm 1994-9510. Susan Reed 1994-9511. Stacey Hirata 1995-9612. Amy Michaels 1995-9613. Gordon Wong 1995-9614. Lori Brown 1995-9615. Christine Hamby 1995-9616. Timothy Brenner 1996-9717. Shikha Kapila 1997-98 18. Michelle Stirrup 1996-98 19. Nicola Bolf 1997-9820. Adam Drzewicki 1998-99 21. Katie Crowley 1998-99 22. Minal Shah 1999-0123. Chris Gadinski 1999-0024. S.Samandari-Gupta 2000-01 25. Hannah Phan 2000-02 26. Marina Kavitanya 2003- 05 27. Jane Crawford 2005-0728. Phung Tran 2005-07 29. Deborah Chu 2006-08 30. Janice Wjotick 2007-0931. Stephanie Dunseith 2008-10 32. Jena Bognaski 2009-11

25/32 research projects have resulted in peer reviewed publications. One is in progress.

31



C. Independent Research Study/Summer research Mentoring -Fourth Professional Year Students mentored2003 George Tsai 2005 Zeina Beydoun 2010 Janice Wojtecki

Undergraduate Research Opportunities ProgramParin Shah 2009-present

B. Seminar Presentations Mentored (College of Pharmacy)

Following students have prepared and presented their seminars under my direction

1. Reginald S. King 1991-922. Carol Welch-Plesky 1992-933. Joseph McKown 1993-944. Susan Reed 1994-955. Bijo Jones 1995-966. Timothy Brenner 1996-977. Joe Terebesi 1997-988. Merilee Shipman 1998-999. John Coombs 1998-9910. Juliann Bultman 1999-0011. Nancy Sheraga 1999-0012. Eric Wong 2000-0113.Trupti Mehta 2000-0114.Seyhoon Samandari-Gupta 2001-0215. Betty Tseng 2001-0216. Brenda Cichon 2002- 0317. Judy Chung 2002-0318. Alicia Fouche 2003-0419. Sandra Kim 2004-0520. Mark Johnson 2004-0521. Deborah Chu 2007-0822. MiNi Paek 2007-08 23. Ruby Leong 2008-09 24. Chitra Mahadeven 2008-09 25. Janice Wojtecki 2009-10 26. Stephanie Dunseith 2009-10 27. Matthew Lewis 2010-11 28. Adina Feng 2010-11

C. Experiential training (Clerkship) Students and Residents mentored

Fourth professional year2007-present NICU Rotation (6-8 Students/year)

32



2003-2005 - NICU rotation (16 Students/yr)1996-2002 - PICU rotation (20 students/yr) 1991-1996 - NICU rotation (12 Students/yr)

Third professional Year1995-2005- 34 Students precepted in NICU or PICU

2009-2010 IPPE Students

International Students2008 3 students (NICU rotation)

Specialty Residents in Pediatrics who completed NICU and/or PICU rotation to date

1992-Present

Patricia Couch Lori KostoffJoanne McDonaldBarry PatelHeather HoppeDarcie StreetmanAkila SubramanianWilliam PrescottBeataDomagalaPetrea Mary CoberDavid HutchinsonKathleen SkillmanJennifer Kwiatowski

33

Documents

CURRICULUM VITAE - University of Michigan College … · Web viewCURRICULUM VITAE Varsha Mehta, MS (Medicinal Chemistry), MS (Clinical Research Design and Statistical Analysis), Pharm.D